Scientists probe genetic secrets of chest cancers to unlock future treatments

NCT ID NCT00242723

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 27 times

Summary

This study aims to collect tumor, normal tissue, and blood samples from up to 1,310 people with cancers of the lung, esophagus, or chest lining. Researchers will analyze genetic and epigenetic changes to better understand these diseases and identify patients who may be eligible for future treatment trials. Participation involves standard medical tests, bronchoscopy, and blood draws, but does not provide direct treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMAS NOS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.